Last updated: 23 July 2019 at 12:12am EST

Frances K Heller Net Worth




The estimated Net Worth of Frances K Heller is at least $2.4 Million dollars as of 13 October 2017. Frances Heller owns over 10,000 units of Bristol-Myers Squibb Co stock worth over $2,330,425 and over the last 16 years Frances sold BMY stock worth over $68,806.

Frances Heller BMY stock SEC Form 4 insiders trading

Frances has made over 10 trades of the Bristol-Myers Squibb Co stock since 2009, according to the Form 4 filled with the SEC. Most recently Frances bought 10,000 units of BMY stock worth $39,000 on 13 October 2017.

The largest trade Frances's ever made was exercising 12,500 units of Bristol-Myers Squibb Co stock on 15 February 2011 worth over $607,375. On average, Frances trades about 3,563 units every 145 days since 2008. As of 13 October 2017 Frances still owns at least 47,961 units of Bristol-Myers Squibb Co stock.

You can see the complete history of Frances Heller stock trades at the bottom of the page.



What's Frances Heller's mailing address?

Frances's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, 345 PARK AVENUE, NEW YORK, NY, 10154.

Insiders trading at Bristol-Myers Squibb Co

Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, and Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.



What does Bristol-Myers Squibb Co do?

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.



Complete history of Frances Heller stock trades at Exelixis Inc, Zafgen, and Bristol-Myers Squibb Co

Insider
Trans.
Transaction
Total value
Frances K Heller
Director
Buy $39,000
13 Oct 2017
Frances K Heller
Director
Buy $32,300
19 Dec 2016
Frances K Heller
Director
Buy $35,400
15 Nov 2016
Frances K Heller
Director
Buy $29,900
22 Jul 2016
Frances K Heller
SVP and Business Development
Option $90,329
10 Mar 2014
Frances K Heller
SVP and Business Development
Option $210,265
1 Oct 2013
Frances K Heller
EVP and Business Development
Option $34,188
15 May 2011
Frances K Heller
EVP and Business Development
Option $125,500
15 Feb 2011
Frances K Heller
EVP and Business Development
Sale $15,655
2 Nov 2009
Frances K Heller
EVP and Business Development
Sale $53,151
3 Jun 2009


Bristol-Myers Squibb Co executives and stock owners

Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: